Get started
Author

Estefanía Luna-Figueroa

Observed names: Estefania Luna-Figueroa, Estefanía Luna-Figueroa, Estefanía Luna Figueroa, Luna-Figueroa Estefania
OpenAlex ID: A5062012678
Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytes
2020 · Omar Lozano, Christian Silva-Platas, et al. · Particle and Fibre Toxicology · 53
PDF
Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation
2025 · Gunnar Weninger, Haikel Dridi, et al. · Journal of Clinical Investigation · 3
Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders
2025 · Marco C. Miotto, Estefania Luna-Figueroa, et al. · Proceedings of the National Academy of Sciences · 3
PDF
Angiotensin II-Induced Hypertrophy in H9c2 Cells Reveals Severe Cytotoxicity of Graphene Oxide
2025 · Estefanía Luna-Figueroa, Judith Bernal-Ramírez, et al. · ACS Omega · 2
Characterization of the cytotoxicity of graphene oxide and reduced graphene oxide in hypertrophic cardiomyocytes
2020 · Estefanía Luna Figueroa
非晶質SiO_2ナノ粒子はラット心臓およびヒト心筋細胞におけるミトコンドリア透過性遷移孔の開口を介して心臓機能障害を促進する【JST・京大機械翻訳】
2020 · Lozano Omar, Silva-Platas Christian, et al.
Additional file 1 of Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytes
2020 · Lozano, Omar, Silva-Platas, Christian, et al. · Figshare
Works count: 7
Citation count: 61
H-index: 3
I10-index: 1
Year
Topic
Type